Brief: Annexin's Rights Issue 98% Subscribed
03/07/2026 12:15
BRIEF-Annexin's Rights Issue 98% Subscribed July 3 (Reuters) - Annexin Pharmaceuticals AB (publ) ANNX.ST:
RIGHTS ISSUE 98% SUBSCRIBED
TO RECEIVE ABOUT 19.9 MSEK BEFORE DEAL COSTS THROUGH RIGHTS ISSUE
Source text: ID:nMFNTWLsg
Further company coverage: ANNX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed